Oragenics Inc (OGEN)

US · Healthcare · Biotechnology

$0.52+3.80%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Net profit

$-2.5M

EPS

$-0.57

Market cap

$2.2M

P/E

0.5

Forward P/E

0.0

P/B

0.61

Book value

$0.81

EPS (TTM)

$0.96

52-week high

$1.45

52-week low

$0.48

50-day MA

$0.53

200-day MA

$0.68

Beta

1.25

Analysts rate Oragenics Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $2.00.

Insiders

1.93%

Institutions

3.06%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Oragenics Inc — free to start.

Data updated 2026-09-18.